Breaking News

Over a quarter ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Alexander & Baldwin to replace Diplomat Pharmacy in S&P 600 at open on 2/13 » 04:55
02/13/20
02/13
04:55
02/13/20
04:55
ALEX

Alexander & Baldwin

$23.02 /

-0.11 (-0.48%)

, DPLO

Diplomat Pharmacy

$4.00 /

+ (+0.00%)

, UNH

UnitedHealth

$303.46 /

+12.62 (+4.34%)

UnitedHealth Group (UNH)…

UnitedHealth Group (UNH) is acquiring Diplomat Pharmacy (DPLO) in a transaction expected to be completed soon.

ShowHide Related Items >><<
ALEX Alexander & Baldwin
$23.02 /

-0.11 (-0.48%)

DPLO Diplomat Pharmacy
$4.00 /

+ (+0.00%)

01/16/20 Credit Suisse
Diplomat Pharmacy downgraded to Underperform from Neutral at Credit Suisse
12/10/19 Deutsche Bank
Deutsche Bank does not expect another bidder for Diplomat Pharmacy
12/10/19 Mizuho
Diplomat Pharmacy unlikely to receive higher takeover bid, says Mizuho
12/09/19 William Blair
Diplomat Pharmacy upgraded to Market Perform from Underperform at William Blair
UNH UnitedHealth
$303.46 /

+12.62 (+4.34%)

02/12/20 Craig-Hallum
Medtronic recall pressures UnitedHealth to bring Tandem back, says Craig Hallum
01/21/20 Cantor Fitzgerald
CVS, Cigna and Centene a buy on any block grant selloff, says Cantor
01/16/20 SunTrust
UnitedHealth price target raised to $360 from $350 at SunTrust
01/16/20 Oppenheimer
UnitedHealth price target raised to $343 from $312 at Oppenheimer
Options
One option delisting on February 11th » 08:30
02/11/20
02/11
08:30
02/11/20
08:30
DPLO

Diplomat Pharmacy

$4.00 /

+ (+0.00%)

Option delistings…

Option delistings effective February 11th include Diplomat Pharmacy Inc (DPLO).

ShowHide Related Items >><<
DPLO Diplomat Pharmacy
$4.00 /

+ (+0.00%)

01/16/20 Credit Suisse
Diplomat Pharmacy downgraded to Underperform from Neutral at Credit Suisse
12/10/19 Deutsche Bank
Deutsche Bank does not expect another bidder for Diplomat Pharmacy
12/10/19 Mizuho
Diplomat Pharmacy unlikely to receive higher takeover bid, says Mizuho
12/09/19 William Blair
Diplomat Pharmacy upgraded to Market Perform from Underperform at William Blair
Hot Stocks
Diplomat Pharmacy trading halted, news dissemination  09:00
02/10/20
02/10
09:00
02/10/20
09:00
DPLO

Diplomat Pharmacy

$4.00 /

+0.01 (+0.25%)

 
ShowHide Related Items >><<
DPLO Diplomat Pharmacy
$4.00 /

+0.01 (+0.25%)

01/16/20 Credit Suisse
Diplomat Pharmacy downgraded to Underperform from Neutral at Credit Suisse
12/10/19 Deutsche Bank
Deutsche Bank does not expect another bidder for Diplomat Pharmacy
12/10/19 Mizuho
Diplomat Pharmacy unlikely to receive higher takeover bid, says Mizuho
12/09/19 William Blair
Diplomat Pharmacy upgraded to Market Perform from Underperform at William Blair
Hot Stocks
Alexander & Baldwin to replace Diplomat Pharmacy in S&P 600 at open on 2/13 » 17:19
02/07/20
02/07
17:19
02/07/20
17:19
ALEX

Alexander & Baldwin

$21.48 /

-0.27 (-1.24%)

, DPLO

Diplomat Pharmacy

$4.00 /

+0.01 (+0.25%)

, UNH

UnitedHealth

$289.22 /

-3.33 (-1.14%)

UnitedHealth Group (UNH)…

UnitedHealth Group (UNH) is acquiring Diplomat Pharmacy (DPLO) in a transaction expected to be completed soon.

ShowHide Related Items >><<
ALEX Alexander & Baldwin
$21.48 /

-0.27 (-1.24%)

DPLO Diplomat Pharmacy
$4.00 /

+0.01 (+0.25%)

01/16/20 Credit Suisse
Diplomat Pharmacy downgraded to Underperform from Neutral at Credit Suisse
12/10/19 Deutsche Bank
Deutsche Bank does not expect another bidder for Diplomat Pharmacy
12/10/19 Mizuho
Diplomat Pharmacy unlikely to receive higher takeover bid, says Mizuho
12/09/19 William Blair
Diplomat Pharmacy upgraded to Market Perform from Underperform at William Blair
UNH UnitedHealth
$289.22 /

-3.33 (-1.14%)

01/21/20 Cantor Fitzgerald
CVS, Cigna and Centene a buy on any block grant selloff, says Cantor
01/16/20 SunTrust
UnitedHealth price target raised to $360 from $350 at SunTrust
01/16/20 Oppenheimer
UnitedHealth price target raised to $343 from $312 at Oppenheimer
01/16/20 Cantor Fitzgerald
UnitedHealth price target raised to $330 from $315 at Cantor Fitzgerald
Downgrade
Diplomat Pharmacy downgraded to Underperform from Neutral at Credit Suisse » 05:36
01/16/20
01/16
05:36
01/16/20
05:36
DPLO

Diplomat Pharmacy

$4.00 /

-0.01 (-0.25%)

, UNH

UnitedHealth

$296.39 /

+8.46 (+2.94%)

Credit Suisse analyst…

Credit Suisse analyst A.J. Rice downgraded Diplomat Pharmacy (DPLO) to Underperform from Neutral with an unchanged price target of $4. With the stock trading at the UnitedHealth (UNH) offer price, there is no possibility of potential upside, while there could be potential downside in the "admittedly highly unlikely" event of a deal break, Rice tells investors in a research note.

ShowHide Related Items >><<
DPLO Diplomat Pharmacy
$4.00 /

-0.01 (-0.25%)

12/10/19 Deutsche Bank
Deutsche Bank does not expect another bidder for Diplomat Pharmacy
12/10/19 Mizuho
Diplomat Pharmacy unlikely to receive higher takeover bid, says Mizuho
12/09/19 William Blair
Diplomat Pharmacy upgraded to Market Perform from Underperform at William Blair
12/09/19 Raymond James
Diplomat Pharmacy downgraded to Market Perform from Outperform at Raymond James
UNH UnitedHealth
$296.39 /

+8.46 (+2.94%)

01/15/20 Stephens
UnitedHealth price target raised to $333 after earnings at Stephens
01/09/20 Roth Capital
Payers 'just need time' to update formularies for Amarin's Vascepa, Roth says
01/08/20 Citi
Amarin selloff on UnitedHealth preferred list reports unwarranted, says Citi
01/08/20 Cantor Fitzgerald
Amarin headline related to UnitedHealth 'just noise,' says Cantor Fitzgerald
Recommendations
Deutsche Bank does not expect another bidder for Diplomat Pharmacy » 08:08
12/10/19
12/10
08:08
12/10/19
08:08
DPLO

Diplomat Pharmacy

$3.91 /

-1.91 (-32.82%)

, UNH

UnitedHealth

$277.56 /

-2.62 (-0.94%)

Deutsche Bank analyst…

Deutsche Bank analyst George Hill does not expect another bidder to emerge for Diplomat Pharmacy (DPLO) given the "more than fair" valuation paid by UnitedHealth (UNH). The analyst, who has a Sell rating on Diplomat, also expects little regulatory pushback. Diplomat exits at 14.9 times the analyst's estimated 2020 EBITDA, which he notes is a "significant premium" to the standalone value of the company.

ShowHide Related Items >><<
DPLO Diplomat Pharmacy
$3.91 /

-1.91 (-32.82%)

12/10/19 Mizuho
Diplomat Pharmacy unlikely to receive higher takeover bid, says Mizuho
12/09/19 William Blair
Diplomat Pharmacy upgraded to Market Perform from Underperform at William Blair
12/09/19 Raymond James
Diplomat Pharmacy downgraded to Market Perform from Outperform at Raymond James
11/15/19 Morgan Stanley
Diplomat Pharmacy 'bull case' value raised to $6 at Morgan Stanley
UNH UnitedHealth
$277.56 /

-2.62 (-0.94%)

12/05/19 Raymond James
UnitedHealth price target raised to $320 from $300 at Raymond James
12/04/19 BMO Capital
UnitedHealth price target raised to $310 from $285 at BMO Capital
12/04/19 Cantor Fitzgerald
UnitedHealth price target raised to $315 from $310 at Cantor Fitzgerald
Recommendations
Diplomat Pharmacy unlikely to receive higher takeover bid, says Mizuho » 07:15
12/10/19
12/10
07:15
12/10/19
07:15
DPLO

Diplomat Pharmacy

$3.91 /

-1.91 (-32.82%)

, UNH

UnitedHealth

$277.56 /

-2.62 (-0.94%)

Mizuho analyst Ann Hynes…

Mizuho analyst Ann Hynes lowered her price target for Neutral-rated Diplomat Pharmacy (DPLO) to $4 from $6 to reflect UnitedHealth's (UNH) take-under buyout. The analyst does not expect any other bidders given Diplomat's outstanding debt and operational challenges. She expects the deal to be completed in January 2020.

ShowHide Related Items >><<
DPLO Diplomat Pharmacy
$3.91 /

-1.91 (-32.82%)

12/09/19 William Blair
Diplomat Pharmacy upgraded to Market Perform from Underperform at William Blair
12/09/19 Raymond James
Diplomat Pharmacy downgraded to Market Perform from Outperform at Raymond James
11/15/19 Morgan Stanley
Diplomat Pharmacy 'bull case' value raised to $6 at Morgan Stanley
11/13/19
Fly Intel: Top five analyst downgrades
UNH UnitedHealth
$277.56 /

-2.62 (-0.94%)

12/05/19 Raymond James
UnitedHealth price target raised to $320 from $300 at Raymond James
12/04/19 BMO Capital
UnitedHealth price target raised to $310 from $285 at BMO Capital
12/04/19 Cantor Fitzgerald
UnitedHealth price target raised to $315 from $310 at Cantor Fitzgerald
12/04/19 Cantor Fitzgerald
UnitedHealth price target raised to $315 from $310 at Cantor Fitzgerald
On The Fly
Fly Intel: Wall Street's top stories for Monday » 17:10
12/09/19
12/09
17:10
12/09/19
17:10
AMZN

Amazon.com

$1,749.61 /

-1.18 (-0.07%)

, MSFT

Microsoft

$151.35 /

-0.42 (-0.28%)

, ARQL

ArQule

$19.71 /

+10.035 (+103.77%)

, THOR

Synthorx

$67.72 /

+42.74 (+171.10%)

, SNY

Sanofi

$45.30 /

-0.755 (-1.64%)

, DPLO

Diplomat Pharmacy

$3.91 /

-1.91 (-32.82%)

, UNH

UnitedHealth

$277.56 /

-2.62 (-0.94%)

, MS

Morgan Stanley

$49.60 /

-0.2 (-0.40%)

, VIAC

ViacomCBS

$38.65 /

-1.05 (-2.64%)

, VIACA

ViacomCBS

$41.78 /

-1.64 (-3.78%)

, FTSV

Forty Seven

$30.44 /

+16.04 (+111.39%)

, FATE

Fate Therapeutics

$19.32 /

+5.68 (+41.64%)

, TTWO

Take-Two

$120.07 /

-3.69 (-2.98%)

, THO

Thor Industries

$64.28 /

-3.485 (-5.14%)

Stocks slid to kick off…

Open Full Text

ShowHide Related Items >><<
AMZN Amazon.com
$1,749.61 /

-1.18 (-0.07%)

12/05/19 BofA
F5 Networks downgraded two notches to Underperform from Buy at BofA/Merrill
12/04/19 B. Riley FBR
Amazon partnership highlights value of TiVo separation, says B. Riley FBR
12/03/19 Citi
Amazon.com transferred with Buy rating, $2,200 target at Citi
12/02/19 Wells Fargo
Wells Fargo says early read on holiday ecommerce data points 'a bit soft'
MSFT Microsoft
$151.35 /

-0.42 (-0.28%)

12/05/19 MKM Partners
Slack may become cash flow positive in next 9-12 months, says MKM Partners
12/05/19 Bernstein
Microsoft price target raised to $174 from $167 at Bernstein
12/05/19 Credit Suisse
Slack Technologies price target lowered to $27 from $35 at Credit Suisse
12/03/19 Stephens
Stephens expects beat-and-raise quarter from Slack Technologies
ARQL ArQule
$19.71 /

+10.035 (+103.77%)

12/09/19 Needham
ArQule downgraded to Hold from Buy at Needham
12/09/19 B. Riley FBR
ArQule downgraded to Neutral from Buy at B. Riley FBR
11/27/19 B. Riley FBR
ArQule resumed with a Buy at B. Riley FBR
11/06/19 SVB Leerink
ArQule data for ARQ 531 'continue to look strong,' says SVB Leerink
THOR Synthorx
$67.72 /

+42.74 (+171.10%)

12/09/19 Evercore ISI
Synthorx downgraded to In Line from Outperform at Evercore ISI
11/11/19 H.C. Wainwright
Synthorx drug may be safer alternative to Nektar's, says H.C. Wainwright
03/15/19 SVB Leerink
Synthorx initiated with an Outperform at SVB Leerink
01/02/19
Fly Intel: Top five analyst initiations
SNY Sanofi
$45.30 /

-0.755 (-1.64%)

12/06/19 Barclays
Barclays downgrades Sanofi to Underweight on 'multiple' Pharma challenges
12/06/19 Barclays
Sanofi downgraded to Underweight from Equal Weight at Barclays
10/15/19 BofA
Europe 1 List changes at BofA/Merrill
10/02/19 Stifel
Stifel remains buyer of Principia Biopharma into Q4 data readouts
DPLO Diplomat Pharmacy
$3.91 /

-1.91 (-32.82%)

12/09/19 William Blair
Diplomat Pharmacy upgraded to Market Perform from Underperform at William Blair
12/09/19 Raymond James
Diplomat Pharmacy downgraded to Market Perform from Outperform at Raymond James
11/15/19 Morgan Stanley
Diplomat Pharmacy 'bull case' value raised to $6 at Morgan Stanley
11/13/19
Fly Intel: Top five analyst downgrades
UNH UnitedHealth
$277.56 /

-2.62 (-0.94%)

12/05/19 Raymond James
UnitedHealth price target raised to $320 from $300 at Raymond James
12/04/19 BMO Capital
UnitedHealth price target raised to $310 from $285 at BMO Capital
12/04/19 Cantor Fitzgerald
UnitedHealth price target raised to $315 from $310 at Cantor Fitzgerald
12/04/19 Cantor Fitzgerald
UnitedHealth price target raised to $315 from $310 at Cantor Fitzgerald
MS Morgan Stanley
$49.60 /

-0.2 (-0.40%)

10/29/19 Odeon Capital
Morgan Stanley downgraded to Hold from Buy at Odeon Capital
10/16/19 BMO Capital
Wells Fargo price target lowered to $57 from $59 at BMO Capital
10/14/19 Keefe Bruyette
Hard for Goldman, Morgan Stanley to justify E-Trade deal, says Keefe Bruyette
10/10/19
Fly Intel: Top five analyst upgrades
VIAC ViacomCBS
$38.65 /

-1.05 (-2.64%)

12/09/19 Evercore ISI
ViacomCBS reinstated with an Outperform at Evercore ISI
VIACA ViacomCBS
$41.78 /

-1.64 (-3.78%)

FTSV Forty Seven
$30.44 /

+16.04 (+111.39%)

12/09/19 Morgan Stanley
Forty Seven reported 'strong' data at ASH meeting, says Morgan Stanley
11/20/19 Guggenheim
Forty Seven assumed with a Buy at Guggenheim
09/12/19 Mizuho
Mizuho starts Forty Seven with Buy rating, $18 price target
09/11/19 Mizuho
Forty Seven initiated with a Buy at Mizuho
FATE Fate Therapeutics
$19.32 /

+5.68 (+41.64%)

12/09/19
Fly Intel: Top five analyst upgrades
12/09/19 BMO Capital
Fate Therapeutics price target lowered to $22 from $26 at BMO Capital
12/09/19 Wells Fargo
Wells Fargo upgrades Fate Therapeutics to Outperform after pipeline updates
12/09/19 Wells Fargo
Fate Therapeutics upgraded to Outperform from Market Perform at Wells Fargo
TTWO Take-Two
$120.07 /

-3.69 (-2.98%)

12/09/19 Stephens
Take-Two's BioShock timeline could pressure shares in near-term, says Stephens
11/13/19 UBS
Take-Two initiated with a Buy at UBS
11/12/19 BMO Capital
Take-Two price target raised to $120 from $110 at BMO Capital
11/08/19 Stephens
Stephens says investors 'looking for clarity' on Take-Two's FY21 slate
THO Thor Industries
$64.28 /

-3.485 (-5.14%)

10/01/19
Fly Intel: Top five analyst downgrades
10/01/19 Northcoast
Update: Thor Industries downgraded to Neutral on valuation at Northcoast
10/01/19 Baird
Thor Industries price target raised to $65 from $60 at Baird
10/01/19 BMO Capital
Thor Industries' Q4 earnings beat 'enough to scare' shorts, says BMO Capital
Upgrade
Diplomat Pharmacy upgraded to Market Perform from Underperform at William Blair » 11:22
12/09/19
12/09
11:22
12/09/19
11:22
DPLO

Diplomat Pharmacy

$3.96 /

-1.865 (-32.04%)

William Blair analyst…

William Blair analyst John Kreger upgraded Diplomat Pharmacy (DPLO) to Market Perform from Underperform after OptumRx, the pharmacy care services business of UnitedHealth Group's (UNH) Optum, agreed to buy the company for $4.00 per share in cash.

ShowHide Related Items >><<
DPLO Diplomat Pharmacy
$3.96 /

-1.865 (-32.04%)

12/09/19 Raymond James
Diplomat Pharmacy downgraded to Market Perform from Outperform at Raymond James
11/15/19 Morgan Stanley
Diplomat Pharmacy 'bull case' value raised to $6 at Morgan Stanley
11/13/19
Fly Intel: Top five analyst downgrades
11/13/19 Barclays
Barclays downgrades Diplomat Pharmacy, cuts target to $3 from $7
Hot Stocks
Diplomat Pharmacy falls -31.7% » 09:47
12/09/19
12/09
09:47
12/09/19
09:47
DPLO

Diplomat Pharmacy

$3.97 /

-1.855 (-31.87%)

Diplomat Pharmacy is down…

Diplomat Pharmacy is down -31.7%, or -$1.84 to $3.97.

ShowHide Related Items >><<
DPLO Diplomat Pharmacy
$3.97 /

-1.855 (-31.87%)

12/09/19 Raymond James
Diplomat Pharmacy downgraded to Market Perform from Outperform at Raymond James
11/15/19 Morgan Stanley
Diplomat Pharmacy 'bull case' value raised to $6 at Morgan Stanley
11/13/19
Fly Intel: Top five analyst downgrades
11/13/19 Barclays
Barclays downgrades Diplomat Pharmacy, cuts target to $3 from $7

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.